Marijuana Laws in Poland 2026: Decriminalization Status and Penalties

Marijuana Laws in Poland 2026: Decriminalization Status and Penalties

Marijuana (cannabis) in Polish legal practice usually means dried cannabis herb (“marihuana”) or cannabis resin (“hashish”) treated as narcotic drugs under Polish law. The key question for companies, foreign nationals, and individuals is not only whether cannabis is “legal,” but what conduct triggers criminal liability, what discretion prosecutors have, and how a case typically develops in practice.

Marijuana laws Poland 2026: is cannabis decriminalized?

As of 2026, Poland has not introduced full decriminalization of marijuana. Possession, cultivation, and supply remain prohibited in principle under the Act of 29 July 2005 on Counteracting Drug Addiction (the “Drug Act”) and may lead to criminal consequences.

However, Poland operates a mixed model that is sometimes described as “partial decriminalization” in public debate. This is because the Drug Act allows discontinuance of proceedings in certain low-level possession cases. This is not the same as legalization. It is a procedural and policy mechanism that depends on the facts, the amount, the circumstances, and prosecutorial assessment.

Cannabis Poland: key offenses and legal bases

In typical cases involving marijuana, the following provisions of the Drug Act are central:

• Possession of narcotic drugs – Article 62 of the Drug Act.
• Discontinuance (opportunity principle) for minor possession – Article 62a of the Drug Act.
• Cultivation of cannabis (including “other than fibrous cannabis”) – Article 63 of the Drug Act.
• Supply / distribution / trafficking – most commonly Article 59 of the Drug Act (in particular udzielanie / facilitating use), with aggravated forms depending on circumstances.

Exact qualification (and the penalty exposure) depends on the factual situation, including the amount, intent, repeated conduct, and evidence of distribution.

Weed penalty Poland: what penalties apply in practice?

Polish law differentiates between possession and supply-type conduct. The business and personal risk profile changes dramatically when facts suggest distribution (even small-scale), because this typically involves pre-trial detention risk, broader searches, phone extractions, and financial scrutiny.

Possession

Possession is criminalized under Article 62 of the Drug Act. The statute provides for different penalty brackets depending on whether the case is treated as basic or as “significant quantity.” Courts assess “significant quantity” based on case law and circumstances, not a single nationwide statutory gram threshold. This makes legal risk harder to predict without a file review.

Supply and related conduct

Supplying another person, even without profit, may be treated as an offense under the Drug Act (commonly Article 59). In practice, messages, payment traces, packaging, scales, and multiple portions can push the case toward a supply narrative. For executives and employees, this can become an immediate reputational and HR crisis if the arrest becomes public or affects security clearances, visas, or internal compliance status.

Cultivation

Cannabis cultivation is regulated separately (Article 63 of the Drug Act). Even “home growing” may trigger criminal liability. From a compliance perspective, cultivation charges often come with property searches and forensic examination of devices and utility usage patterns.

Marijuana decriminalization: the three practical “exceptions” under Polish law

The following mechanisms are commonly perceived as “exceptions.” They do not legalize cannabis. They are limited legal pathways that can reduce or eliminate penal consequences in defined circumstances.

1. Discontinuance for a small amount for personal use (Article 62a of the Drug Act)

   Proceedings may be discontinued when the offender possesses a small amount of drugs for personal use and punishing the offender would be inexpedient due to the circumstances of the act and the degree of social harm. This is discretionary and depends on the full context, including prior history and how the evidence was obtained.

2. Privileged type of possession: “small amount” for personal use

   Correction: The Act does not provide a separate privileged type in Article 62(3) for possession of a “small amount for personal use.” Article 62 covers (i) the basic type of possession and (ii) possession of a significant quantity as a qualified (more serious) type. In practice, mitigation for minor cases occurs primarily via Article 62a (discontinuance) and general sentencing rules, depending on the evidence and circumstances.

3. Medical cannabis is legal under strict rules (Pharmaceutical Law and the Drug Act framework)

   Cannabis-based medicinal products may be lawful when obtained and used in compliance with Polish pharmaceutical regulations (including prescription-based access and authorized distribution). This does not legalize recreational marijuana. For foreign patients and cross-border travelers, documentation and product form matter for risk assessment at border checks and during police interventions.

What “small amount” means in Poland – why companies and foreigners should be cautious

Polish statutes do not set a universal numeric threshold for “small amount” across all fact patterns. Authorities consider the substance type, potency, form, packaging, and whether the amount suggests personal use versus distribution. As a result:

• Borderline cases may be treated differently depending on the district and the file narrative.
• Evidence of distribution (messages, transfers, multiple baggies) often outweighs arguments about quantity.
• Repeat contact with law enforcement makes Article 62a discontinuance less likely in practice.

Procedure and business impact: searches, phones, and reputational exposure

Marijuana cases frequently start with stop-and-search, apartment searches, or third-party allegations. Even a minor allegation can quickly expand into a broader review of contacts and finances. Typical operational consequences include:

• Device seizure and forensic extraction (risk of accessing business communications and client data).
• Pre-trial measures such as police supervision or travel restrictions, depending on the case.
• Employment implications in regulated sectors, security-sensitive roles, and for foreigners holding permits.
• Reputation risk if the matter becomes public or intersects with internal reporting channels.

For a broader overview of drug-related exposure and defense planning in Poland, see KKZ materials on drug offenses and procedural strategy: drug-related offenses in Poland. Sentencing mechanics, including conditional suspension where legally available, are discussed here: suspended sentences in Poland.

Risk management: practical steps after detention or charges

• Secure the procedural status – suspect vs witness status drives rights and obligations.
• Verify the legal basis for search and seizure – irregularities may affect evidence usability.
• Control communications – avoid “explaining by message,” which often becomes key evidence.
• Assess diversion options early – Article 62a discontinuance may depend on initial actions and consistency.
• For companies – separate HR, compliance, and legal tracks; secure data and confidentiality; document decisions for audit purposes.

This is informational material, not legal advice. The appropriate legal assessment depends on the evidence, procedural posture, and the specific factual scenario.

If a criminal matter involves sensitive allegations, including sexual offense accusations that may arise alongside reputation or employment consequences, it is often important to consult the case early and obtain a structured assessment of the situation. To discuss possible next steps with a lawyer, contact Kopeć & Zaborowski (KKZ) via https://criminallawpoland.com/contact/.

FAQ + Marijuana Laws in Poland 2026: Decriminalization Status and Penalties

Is marijuana legal in Poland in 2026?

No. Recreational marijuana remains illegal. Possession, cultivation, and supply are prohibited in principle under the Act on Counteracting Drug Addiction, subject to limited procedural mechanisms for minor cases.

Has Poland decriminalized cannabis?

Not fully. Poland allows discretionary discontinuance for small amounts intended for personal use (Article 62a of the Drug Act), but this is not legalization and is not guaranteed.

What is the penalty for weed in Poland for simple possession?

Penalty exposure depends on qualification under Article 62 of the Drug Act, including whether the case is treated as the basic type or as a “significant quantity” type. A precise assessment requires review of the amount, circumstances, and evidence.

Is there a fixed gram limit for “small amount” in Poland?

No single statutory threshold applies across all cases. Authorities and courts assess “small amount” based on the circumstances, including indications of personal use versus distribution.

Can medical cannabis be used legally in Poland?

Yes, but only within the regulated framework for medicinal products, typically based on a valid prescription and lawful distribution channels. This does not legalize recreational possession.

Does giving a joint to a friend count as a crime?

It can. Providing or facilitating another person’s use may be treated as a supply-related offense under the Drug Act (often Article 59). Legal risk depends on the facts, evidence, and prosecutorial qualification.

Can foreigners face immigration problems after a marijuana case in Poland?

Yes. Even non-custodial outcomes can affect permits, background checks, and travel risk. The impact depends on the case result, the person’s status, and administrative rules applied by the competent authority.

Bibliography

1. Act of 29 July 2005 on Counteracting Drug Addiction (Journal of Laws – consolidated text, as amended) – in particular Articles 59, 62, 62a, 63. [1]
2. Act of 6 June 1997 – Code of Criminal Procedure (Journal of Laws – consolidated text, as amended). [2]
3. Act of 6 June 1997 – Criminal Code (Journal of Laws – consolidated text, as amended). [3]
4. Act of 6 September 2001 – Pharmaceutical Law (Journal of Laws – consolidated text, as amended). [4]